Table 8.
Comparison of rank by number of citations per year and total citations.
| Authors | Title | Average per Year | Rank by average | Rank by Total |
|---|---|---|---|---|
| Carragee et al.6 | A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned | 76.6 | 1 | 9 |
| Harms et al.17 | Posterior C1-C2 fusion with polyaxial screw and rod fixation | 41.6 | 2 | 5 |
| Vernon et al.9 | The neck disability index - A study of reliability and validity | 38.36 | 3 | 2 |
| Hilibrand et al.23 | Radiculopathy and myelopathy at segments adjacent to the site of a previous anterior cervical arthrodesis | 37.71 | 4 | 4 |
| Silber et al.25 | Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion | 30.69 | 5 | 7 |
| Shields et al.22 | Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion | 28.7 | 6 | 20 |
| Hoffman et al.24 | Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. | 27.31 | 7 | 6 |
| Murrey et al.81 | Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational, device exemption study of the ProDisc-C total disc replacement versus anterior discectomy andfusion for the treatment of 1-level symptomatic cervical disc disease | 25.86 | 8 | 69 |
| Frankel et al.7 | The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. | 25.68 | 9 | 1 |
| Heller et al.91 | Comparison of BRYAN Cervical Disc Arthroplasty With Anterior Cervical Decompression and Fusion Clinical and Radiographic Results of a Randomized, Controlled, Clinical Trial | 24.43 | 10 | 80 |